Comments
Sotac Pharmaceuticals said it has made further investments to the extent of about ₹5 crore in its subsidiary company, Sotac Lifesciences Private Limited (SLPL) by way of subscription of 51 lakh fully paid-up equity shares of face value ₹10 each.
On Friday, the subsidiary company allotted 51 lakh equity shares of face value of ₹10 each at cash for the total consideration of about ₹5 crore to the holding company. Subsequent to allotment of 51 lakh equity shares by SLPL, holding of Sotac Pharmaceuticals Limited in SLPL has increased to 51.26 percent from 51 per cent of equity share capital of Sotac Lifesciences.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.